Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Oy Melior Pharma Ab
OY
Active
Y-tunnus 3104954-4
Pl 143, 65101
Vaasa
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 6 years old
— employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Oy Melior Pharma Ab
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
0
400
5
2
22
Staff expenses
−0
−12
−0
−0
−0
EBITDA
−3
−1
−2
−8
3
Depreciation & amort.
−0
−21
−0
−0
−0
EBIT
−3
−1
−3
−8
3
Net financials
−2
481
−8
−1
−1
Profit before tax
−4
389
−10
−9
2
Tax
−0
−0
−0
0
0
Net profit
−4
389
−10
−9
2
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
16
2 088
12
25
34
Equity
−8
−4
−8
3
12
Long-term debt
20
1 951
18
20
20
Short-term debt
4
519
2
3
2
Total debt
24
2 471
20
23
22
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
−52,7 %
This company
38,2 %
Market median
This company
Market median
238% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
View
PDF
More on Oy Melior Pharma Ab
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
